英文名稱 Anti-CYLD

中文名稱 微管結(jié)合蛋白CYLD抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Chicken, Cow, Horse

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 細(xì)胞類型標(biāo)志物

蛋白分子量 predicted molecular weight: 105kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humancylindromatosis 1

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 CDMT; cylindromatosis (turban tumor syndrome);cylindromatosis 1; Deubiquitinating enzyme CYLD; EAC; HSPC057; KIAA0849; turbantumor syndrome; Ubiquitin thiolesterase CYLD; Ubiquitin-specific processingprotease CYLD; CYLD_HUMAN; Ubiquitin carboxyl-terminal hydrolase CYLD; CYLD;BRSS; CDMT; CYLD1; CYLDI; EAC; MFT; MFT1; SBS; TEM; USPL2.